Eculizumab in adolescents with PT-sensitive aHUS

• Research type

  Research Study

• Full title

  An open-label, multi-centre controlled clinical trial of Eculizumab in adolescent patients with plasma therapy-sensitive atypical Haemolytic-Uremic Syndrome (aHUS)

• IRAS ID

  18414

• Contact name

  Timothy H. J. Goodship

• Contact email

  t.h.j.goodship@ncl.ac.uk

• Sponsor organisation

  Alexion Pharmaceuticals, Inc

• Eudract number

  2008-006955-28

• ISRCTN Number

  N/A

• Research summary

  Research Summary not published at request of researcher

• REC name

  North East - Newcastle & North Tyneside 1 Research Ethics Committee

• REC reference

  09/H0906/44

• Date of REC Opinion

  28 May 2009

• REC opinion

  Further Information Favourable Opinion